FDA Inspection 1252050 — MACSEN DRUGS
The FDA completed an inspection of MACSEN DRUGS on Sep 6, 2024 in Udaipur. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Sep 6, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Udaipur (India)